| 73.03 -0.65 (-0.88%) | 07-16 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 88.97 | 1-year : | 92.1 |
| Resists | First : | 76.18 | Second : | 78.86 |
| Pivot price | 75.43  |
|||
| Supports | First : | 71.84 | Second : | 59.77 |
| MAs | MA(5) : | 74.09 |
MA(20) : | 74.93 |
| MA(100) : | 72.91 |
MA(250) : | 69.97  |
|
| MACD | MACD : | 0.1 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 19.9 |
D(3) : | 27.8 |
| RSI | RSI(14): 43.8 |
|||
| 52-week | High : | 85.91 | Low : | 52.4 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ SOLV ] has closed above bottom band by 13.4%. Bollinger Bands are 28.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 73.84 - 74.3 | 74.3 - 74.63 |
| Low: | 70.94 - 71.52 | 71.52 - 71.93 |
| Close: | 72.27 - 73.12 | 73.12 - 73.72 |
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Mon, 14 Jul 2025
Thermo Fisher Wins EU Approval for Acquisition of Solventum's Filtration Business - MarketScreener
Fri, 11 Jul 2025
Solventum Corp. Stock Falls Tuesday, Underperforms Market - 富途牛牛
Wed, 09 Jul 2025
Solventum Corp (SOLV) Upgraded to a ‘Buy’ at Argus Research - Insider Monkey
Wed, 09 Jul 2025
Solventum Corp (SOLV) Upgraded to a ‘Buy’ at Argus Research - Yahoo
Mon, 07 Jul 2025
Is the Options Market Predicting a Spike in Solventum Stock? - TradingView
Fri, 04 Jul 2025
Solventum (NYSE:SOLV) Stock Rating Upgraded by Argus - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 173 (M) |
| Shares Float | 138 (M) |
| Held by Insiders | 20 (%) |
| Held by Institutions | 67.8 (%) |
| Shares Short | 4,200 (K) |
| Shares Short P.Month | 4,610 (K) |
| EPS | 2.17 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.85 |
| Profit Margin | 4.5 % |
| Operating Margin | 7.7 % |
| Return on Assets (ttm) | 3.7 % |
| Return on Equity (ttm) | 10.6 % |
| Qtrly Rev. Growth | 2.7 % |
| Gross Profit (p.s.) | 26.35 |
| Sales Per Share | 48.03 |
| EBITDA (p.s.) | 8.2 |
| Qtrly Earnings Growth | -43.1 % |
| Operating Cash Flow | 772 (M) |
| Levered Free Cash Flow | 1,050 (M) |
| PE Ratio | 33.65 |
| PEG Ratio | 0 |
| Price to Book value | 3.87 |
| Price to Sales | 1.52 |
| Price to Cash Flow | 16.36 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|